Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 5,254 | 5,920 | 2,854 | 2,534 | 3,229 |
| Operating Income | -5,254 | -5,920 | -2,854 | -2,534 | -3,229 |
| Other Income | 20 | 6 | 6 | 10 | 30 |
| Pre-tax Income | -5,234 | -5,915 | -2,848 | -2,525 | -3,200 |
| Net Income Continuous | -5,234 | -5,915 | -2,848 | -2,525 | -3,200 |
| Net Income | $-5,234 | $-5,915 | $-2,848 | $-2,525 | $-3,200 |
| EPS Basic Total Ops | -0.64 | -0.75 | -0.35 | -0.34 | -0.46 |
| EPS Basic Continuous Ops | -0.64 | -0.74 | -0.35 | -0.34 | -0.46 |
| EPS Diluted Total Ops | -0.64 | -0.75 | -0.35 | -0.34 | -0.46 |
| EPS Diluted Continuous Ops | -0.64 | -0.74 | -0.35 | -0.34 | -0.46 |
| EBITDA(a) | $-5,254 | $-5,920 | $-2,854 | $-2,534 | $-3,229 |